Ia VERSUS K/D ANTIGENS IN IMMUNOLOGICAL ENHANCEMENT OF TUMOR ALLOGRAFTS

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Transplantation

• Publication date

  1978-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00007890-197804000-00005PMID 635985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antigen-antibody reactions in gels.

  2009cited by this paper
• A Cardinal Role for I‐Region Antigens (Ia) in Immunological Enhancement, and the Clinical Implications

  1976cited by this paper
• THE EFFECTS OF ERYTHROCYTE‐ABSORBED H‐2 ALLOANTISERA ON MIXED LYMPHOCYTE CULTURE REACTIONS

  1976cited by this paper
• The dominant role of la antibodies in the passive enhancement of H‐2 incompatible skin grafts

  1975cited by this paper
• Tissue distribution of I region-associated antigens in the mouse.

  1974cited by this paper
• What Abrogates Heart Transplant Rejection in Immunological Enhancement?

  1974cited by this paper
• Studies on the mechanism of immunological enhancement of tumor homografts. II. Effect of isoantibodies on various tumor cells.

  1963cited by this paper
• THE SURVIVAL OF HOMOGRAFTS IN MICE PRETREATED WITH ANTISERA TO MOUSE TISSUE

  1957cited by this paper
• The antibody response to tumor inoculation; improved methods of antibody detection.

  1954cited by this paper

• Cellular stimuli for rejection of sarcoma I tumor allografts by BALB/c recipient mice.

  1989cites this paper
• Realm of Tolerance

  1989cites this paper
• Role of MHC Class I Antigens in Tumor Rejection

  1987cites this paper
• Allogeneic H-2 antigen expression is insufficient for tumor rejection.

  1987cites this paper
• The role of RT1 antigen differences in semi-allogeneic rat pregnancy.

  1987cites this paper
• Evolution of alloantibodies and suppressor cells in allografted mice treated for passive enhancement.

  1985cites this paper
• Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.

  1983cites this paper
• ROLE OF ANTIBODY IN RAT RENAL ALLOGRAFT REJECTION: II. FAILURE TO ENHANCE RENAL ALLOGRAFTS BY SENSITIZATION TO DONOR CLASS I ANTIGENS PRESENTED BY DONOR STRAIN ERYTHROCYTES

  1983cites this paper
• The role of target antigens coded by subregions of the mouse H-2 complex in the nature of growth of sarcoma I tumor allograft.

  1983cites this paper
• Suppressor cells as an agent of immune facilitation. II. Adoptive transfer of passively induced enhancement of allografted tumors.

  1982cites this paper
• Interacting genetic factors controlling the antibody response against the H-2.2 specificity

  1982cites this paper
• PASSIVE ALLOGRAFT ENHANCEMENT BY SUBCLASSES OF POLYCLONAL ANTIBODIES DIRECTED TOWARD RESTRICTED REGIONS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX

  1982cites this paper
• Involvement of suppressor cells in active enhancement of allografted tumors. In vivo (adoptive transfer) and in vitro (MLR) evaluation. Synergy with enhancing antibodies.

  1981cites this paper
• Immunological enhancement can be mediated by anti-Ia and anti-K,D antibodies.

  1980cites this paper
• Immunosuppressive effect of murine alloantibody giving only partial H-2 cover.

  1980cites this paper
• Suppression of Rat Renal Allograft Rejection by Antigen and Antibody

  1980cites this paper
• Cardiac allograft rejection and enhancement in natural recombinant rat strains.

  1980cites this paper
• The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.

  1980cites this paper
• Suppression of Rejection of Organ Allografts by Alloantibody *

  1980cites this paper
• Role of Antibody Classes in the Regulatory Facilitation Reaction

  1980cites this paper
• Effect of enhancing antibodies on the generation of cytotoxic T cells in vivo and in vitro.

  1980cites this paper
• Distribution and quantitation of HLA-ABC and DR (Ia) antigens on human kidney and other tissues.

  1980cites this paper
• SKIN GRAFT ENHANCEMENT STUDIES WITH ANTIGENIC DIFFERENCES ARISING FROM THE H‐2K, H‐2D, AND H‐2L LOCI

  1980cites this paper
• Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.

  1979cites this paper
• Specific suppression by alloantibodies: passive enhancement.

  1979cites this paper
• Enhancement of heart allograft survival across H-2D differences.

  1979cites this paper
• The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts

  1979cites this paper